Safety and FDA regulations for musculoskeletal allografts: perspective of an orthopaedic surgeon.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15930917.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Musculoskeletal Transplant Foundation Symposium held in September 2003, in Edinburgh, Scotland provided the opportunity for an orthopaedic surgeon experienced in tissue banking and musculoskeletal allograft transplantation to summarize to orthopaedic colleagues the past and current efforts made by the Food and Drug Administration to ensure the safety of allograft tissues, aspects of tissue banking, concerns of allograft safety and future Food and Drug Administration proposals. The review allows an orthopaedic surgeon an understanding of allograft safety issues and provides information for better informed consent to be obtained by the orthopaedic surgeon from the recipient patient.
Medical subject headings
- Bone Transplantation
- Orthopedics
- Quality Assurance, Health Care
- Tissue Transplantation